OMX Copenhagen 25 GI (OMXC25GI.CO)

Cours de clôture: 1 898.03 (+5.10), 25. avr 2025
Négatif

Bas risk

Automatic technical analysis. Moyen terme, 25. avr 2025

OMX Copenhagen 25 GI a franchi le plancher d'un canal baissier et annonce donc une baisse encore plus accentuée. Cependant, le déclin peut renforcer la probabilité des rebondissements à partir des niveaux de cours d’en ce moment. L'indice a une résistance à environ 2030 points. L'indice est considéré comme negatif technique pour moyen long terme.

Recommendation one to six months: Négatif (Score: -91)

Période  
Vol.bal. Volatilité Liquidité +/- %
1 jour-0.75%0.00+0.27%
5 jours0.002.51%0.00+0.59%
22 jours0.006.11%0.00-8.37%
66 jours0.0010.93%0.00-6.47%

More analyses of OMX Copenhagen 25 GI

chart OMX Copenhagen 25 GI (OMXC25GI) Chandeliers 22 Days
Candlesticks
chart OMX Copenhagen 25 GI (OMXC25GI) Court terme
Court terme: Conclusion légèrement négative
chart OMX Copenhagen 25 GI (OMXC25GI) Moyen terme
Moyen terme: Négatif
chart OMX Copenhagen 25 GI (OMXC25GI) Long terme
Long terme : Positif
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Samtykke

Vi bruger cookies for at give dig en bedre brugeroplevelse. Hvis du fortsætter med at bruge hjemmesiden, accepterer du dette. For yderligere detaljer klik her.